Advancing Global Patient Access
to Novel Radiopharmaceuticals
Who We Are
PharmaLogic advances global patient access to radiopharmaceuticals through a combination of infrastructure, expertise, and trusted partnerships.
Our Mission
To improve global patient access to novel radiopharmaceuticals.
Our Heritage
Over time, PharmaLogic has evolved from a footprint of radiopharmacies in secondary and tertiary markets—established through strategic acquisitions—into a globally integrated platform supporting radiopharmacy, PET manufacturing, and comprehensive radiopharmaceutical CDMO capabilities. Although our focus has expanded, our mission of advancing patient access to novel radiopharmaceuticals has remained steadfast. Today, this scalable global infrastructure enables sponsors to efficiently develop and commercialize diagnostic and therapeutic radiopharmaceuticals worldwide.
Our People
Our people are the foundation of what we do. United by a shared mission, we bring an entrepreneurial spirit to every challenge—empowering all to take ownership and deliver meaningful impact.
Environmental, Social, & Governance
Our commitment to compliance and ethical governance is fundamental to how we operate. Grounded in ESG principles, we hold ourselves to the highest standards of integrity while advancing novel radiopharmaceuticals responsibly and sustainably. Likewise, we incorporate green business practices that strengthen long-term operational and organizational resilience.
Careers
Big ideas keeping you up at night?
Join our team.
Get in Touch
Have a question? Our team is ready to help you find the right solutions for your clinical and operational needs.